![Michael Amoroso](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Amoroso
Algemeen Directeur bij
PRECISION BIOSCIENCES, INC.
Vermogen: 3 M $ op 31-05-2026
Profiel
Michael Amoroso is President, Chief Executive Officer & Director at Precision BioSciences, Inc. since 2021.
Formerly, Mr. Amoroso was Chairman at Abeona Therapeutics, Inc. from 2021 to 2026, Senior Vice President-Americas at Eisai, Inc. from 2017 to 2018, and SVP & Head-Cell Therapy Worldwide Commercial at Kite Pharma, Inc. from 2018 to 2020.
Education includes undergraduate studies at Rider University and an MBA from The Leonard N Stern School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-06-2026 | 243.392 ( 1,01% ) | 2 M $ | 31-05-2026 | |
| 15-04-2026 | 217.779 ( 0,38% ) | 1 M $ | 31-05-2026 |
Actieve functies van Michael Amoroso
| Bedrijven | Functie | Begin |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Algemeen Directeur | 15-10-2021 |
Eerdere bekende functies van Michael Amoroso
| Bedrijven | Functie | Einde |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Algemeen Directeur | 14-10-2021 |
| KITE PHARMA INC | Corporate Officer/Principal | 01-01-2020 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Corporate Officer/Principal | 01-08-2018 |
Opleiding van Michael Amoroso
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Precision BioSciences, Inc.
 Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Rider University
 Rider University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
